Dr. Steve Cutler was appointed Group President, Clinical Research Services in November 2011.
Steve has over 23 years’ experience within the pharmaceutical and CRO industry and joined ICON from Kendle where he held the position of Chief Executive Officer, having previously served as Kendle’s Chief Operating Officer. Prior to Kendle, Steve spent 14 years with Quintiles where he served as Senior Vice President, Global Project Management; Senior Vice President, Clinical, Medical and Regulatory; Senior Vice President, Project Management - Europe; and Vice President, Oncology - Europe as well as regional leadership positions in South Africa and Australia. Prior to joining Quintiles, Steve held positions with Sandoz (now Novartis) in Australia and Europe. He holds a B.Sc. and a PhD from the University of Sydney and a Masters of Business Administration from the University of Birmingham (UK).
Mark has been in clinical research for over 25 years. His most recent position prior to joining ICON was at Kendle/INC where he was Executive Vice President of Business Development. Previously Mark spent 12.5 years at PPD where he held senior management positions in both operations and business development. While at PPD, Mark provided oversight to all project management and clinical operations staff based in North Carolina and supervised the oncology, cardiovascular, anti-infective, and respiratory therapeutic areas. Prior to PPD, Mark spent six years at CIBA Vision where he supervised all data management, clinical operations, biostatistics, and medical writing activities and was responsible for the conduct of their registration trials.
Mark earned his M.P.H. (Master's of Public Health) and D.Sc. (Doctor of Science) degrees in epidemiology from Boston University.
Jonathan joined ICON Clinical Research in April 2010 to lead the Strategic Programs group, with responsibility for strategic relationships and management of external alliances. In December of 2010 he was appointed to the position of Executive Vice President of Business Development, with responsibility for Global Business Development. Prior to joining ICON Clinical Research, he served as Chief Medical Officer and Senior Vice President of Medical Affairs at ICON Medical Imaging. From 2001–2007, he was Chief Medical Officer and Vice President of Medical Affairs at Point Biomedical, a development-stage biopharmaceutical company, with responsibility for medical affairs, clinical and scientific operations; he lead development efforts for a cardiovascular asset from phase 1 to NDA.
Jonathan has BSc (1986), MBBS (1989) and MD (1995) degrees from the University of London, and with Executive MBA qualifcations from Columbia University in New York, and the University of California at Berkeley. He is certified in internal medicine, cardiology and several cardiac subspecialties. Jonathan has authored over 100 scientific publications and is a Fellow of prominent medical societies, including the American College of Cardiology, and the Royal College of Physicians in the UK. He currently maintains a Faculty appointment as an Associate Clinical Professor of Medicine at the University of California, San Francisco and serves as attending Cardiologist at the San Francisco Veterans’ Administration Medical Center.
Nuala has over 20 years’ experience within the pharmaceutical and CRO industry. She joined ICON in 2012 from Quintiles where she headed a clinical workforce in Europe and Africa (since 2009).
Nuala also has over a decade of experience in therapeutics having headed the CNS and internal medicine project management divisions for Quintiles. Prior to this, Nuala held a position in the field of late phase clinical research at Benefit International.
Nuala graduated from Trinity College Dublin with first class honours in Biochemistry, was awarded a PhD in neurochemistry, from the Department of Cardiovascular Studies in Leeds, and conducted post-doctoral research in the Department of Neuropharmacology at the Collège de France in Paris. During her tenure, she published extensively in eminent peer reviewed journals.
Simon has over 20 years’ experience in the pharmaceutical industry, most recently focusing on Asia-Pacific. Prior to joining ICON, Mr. Britton was Vice President, Clinical Development, Asia-Pacific at PPD, where he was responsible for developing, overseeing and executing the company’s development strategy within the region.
Simon managed the International Clinical Operations division at GlaxoSmithKline from 2000 – 2007, a role which involved the management of clinical activities in 25 countries. Simon has also held senior business development and operational roles at INC Research and Parexel.
Dana has been with the company since March 1997, she initially joined as a Project Manager. Dana has held positions of increasing responsibility at ICON inclusive of Senior Vice President, US Clinical Operations for 5 years. Dana’s clinical research experience began as a CRA progressing to Project Manager during five years with ClinTrials Research. She began her career in health care as a neonatal intensive care nurse at Vanderbilt University prior to entering clinical research industry.
Kevin joined ICON in November 2010 with more than 25 years of senior leadership experience in the global technology business.
As Senior Executive with Accenture, Kevin led Accenture’s European Shared Services and Global Procurement organizations. He also ran Business Processing Outsourcing (BPO) operations for a large European client. As Vice President and Managing Director with Oracle, Kevin led the development of a European Operations Centre encompassing Software Distribution, Development, Teleservices and e-Commerce. Most recently, as Chief Operating Officer with NewScope Group Holdings (a Swiss based Private Venture Capital company), Kevin was responsible for Business Development and Operations for a number of early stage technology/pharmaceutical companies.
Kevin holds an MBA from Santa Clara University and a First Class Honours degree in Engineering from Trinity College Dublin. Kevin also holds a BA in Maths from Trinity College Dublin.
Malcolm currently has responsibility for the ongoing design and development of ICON’s integrated information platform, ICONIK. Prior to relocating back to the USA in 2012, Malcolm was based in Hong Kong with responsibility for the management, growth and development of ICON’s Asia Pacific organisation.
From 2006-2009, Malcolm was the Chief Operating Officer, US Clinical Research division, with additional global leadership roles in Biometrics and Interactive Technologies. He joined ICON in December 2002 as Senior Vice President, Biometrics, and Data Management. Prior to joining ICON, Malcolm held the position of Executive Director, Global Electronic Data Capture Logistics for Novartis. He has over 30 years experience within the Pharmaceutical sector having held various Research and Development positions within Novartis, Hoechst Marion Roussel and SmithKline Beecham.
Malcolm holds a BSc in Chemistry from University College, London and a Doctorate in Biochemistry and Physiology from Bath University, UK.
Grace is a Senior Director of Quality Assurance at ICON Clinical Research and has spent over 19 years in the pharmaceutical industry in the areas of clinical research and quality assurance.
Her main responsibilities include implementing and maintaining an effective GCP Quality Assurance program and leading the global QA function for the Clinical Research division of ICON.
Prior to joining ICON, Ms. Crawford was a Medical Technologist at the Bryn Mawr Hospital for 7 years. In addition to her laboratory responsibilities, she was a member of the Total Quality Management Team and assisted in the Total Quality Improvement efforts of the laboratory that she worked in. Ms. Crawford has received a M.Sc. in Clinical Microbiology from the Medical College of Pennsylvania and has been an active member of organisations such as ASQ, Local Clinical Quality Assurance Discussion Groups, SQA, SQA’s Clinical Specialty Section, MARSQA and MARSQA’s Computer Validation Committee, and DIA.
Will joined ICON in April 2011. He has extensive experience and a proven track record in delivering IT services in Clinical Development. Prior to ICON, Will was at GSK where he most recently led the business systems support team. He also held various leadership roles in GSK Research & Development IT and had a major role in developing and delivering GSK’s “Simplifying Clinical Development” programme.
Wei Ming Goh joined ICON in September 2012. He has over 14 years’ experience within the CRO industry and a strong track record in Asia Pacific.
He joins ICON from Kendle where he was Vice President, Asia Pacific, responsible for all operational activities and partner relationships within the region. Prior to this, Wei Ming spent 11 years with Quintiles, and held a number of senior management positions in operations and finance for the company’s Asian, Australian and African region. Wei Ming has also held senior roles in Asia with Autodesk, The Ask Group and Hitachi Data Systems.
Wei Ming holds a Bachelor of Accountancy from the National University of Singapore and an MBA from Cranfield School of Management in the UK.
Dr. Dennis Hurley joined ICON in September 2012. Denis has over 30 years’ experience within the drug development industry. Prior to joining ICON Denis was Vice President Latin America at INC. he was responsible for building the company’s business in the region.
Dennis co-founded ECA, Mexico’s largest CRO, in 1992 and expanded it to the five other major countries in Latin America. As well as his operational leadership in clinical development, Dennis has a strong background in biostatistics, process improvement and project management and has contributed significantly to a number of approved NDAs.
Dennis holds a Doctor of Science (Mathematics) from the National Polytechnic Institute in Mexico and a Post Doctorate in Biostatistics from the University of North Carolina at Chapel Hill.